Walgreens executive chair set to double stake in $10 billion Sycamore takeover, FT reports

Published 18/03/2025, 08:42
© Reuters.

Investing.com -- Stefano Pessina, the executive chair of Walgreens Boots Alliance (NASDAQ:WBA), is set to increase his stake in the U.S. pharmacy group to approximately 30% as part of a $10 billion takeover by private equity group Sycamore, according to the Financial Times on Tuesday.

Pessina, who is currently the top shareholder of Walgreens with a stake of about 17%, will contribute cash to the company as part of this deal, the report said.

This move will see Pessina’s stake in Walgreens nearly double from its current level, it said, adding that Pessina will deepen his involvement in the group, a move that comes ahead of a potential split of the company.

Sycamore has plans to divide Walgreens into three separate entities: a U.S. retail pharmacy, Boots UK, and U.S. healthcare. This plan was initially reported by FT in February.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.